HOME >> BIOLOGY >> NEWS
Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies

ed States Representative (N.Y.)

  • The Honorable Joseph L. Bruno, New York State Senate Majority Leader

  • The Honorable Elias Zerhouni, M.D., Director, National Institutes of Health

  • Bruce Alberts, Ph.D. President, National Academy of Sciences

  • Samuel Heffner Jr. '56, Chairman, Board of Trustees, Rensselaer Polytechnic Institute

  • Howard P. Isermann '42, Honorary Trustee, Rensselaer Polytechnic Institute

  • Robert E. Palazzo, Ph.D., Acting Director, Center for Biotechnology and Interdisciplinary Studies and Chair, Department of Biology, Rensselaer Polytechnic Institute

    "This extraordinary group of leaders in the sciences, engineering, business and government is rarely assembled in one place, and their participation is a testament to what the Rensselaer community has accomplished in a few short years," said Rensselaer President Shirley Ann Jackson. "By establishing the Center for Biotechnology and Interdisciplinary Studies, we have created a gathering place where scientists and engineers from various disciplines will explore at the intersection of the life sciences, with engineering and the physical and information sciences, thereby accelerating discovery and ultimately enhancing the quality of life for all people."

    Rensselaer's new center ranks among the world's most advanced research facilities focused on the application of engineering and the physical and information sciences to the life sciences. The Center for Biotechnology and Interdisciplinary Studies is a 218,000-square-foot, $100 million facility (including $80 million for construction). With its high-tech laboratories and expansive atrium, it provides a platform for collaboration among many diverse academic and research disciplines to enhance discovery and encourage innovation.

    The Center is designed to foster the multidisciplinary nature of biotechnology. It is organized around "constellations" of research Biocomputation and Bioin
    '"/>



  • Contact: Theresa Bourgeois
    bourgt@rpi.edu
    518-276-2840
    Rensselaer Polytechnic Institute
    2-Sep-2004


    Page: 1 2 3 4

    Related biology news :

    1. Rensselaer receives NIH grant to develop virtual surgery simulator
    2. New software developed at Rensselaer predicts promising ingredients for new drugs
    3. Rensselaer awarded $2.7 million NIH grant to improve drug development process
    4. National Institutes of Health grant to Rensselaer to further research on healing bone injuries
    5. Kimberly-Clark Worldwide donates intellectual property to Rensselaer
    6. Rensselaer effort to pull mussels at Lake George looks promising
    7. NASA Funds New Origin Of Life Center at Rensselaer Polytechnic Institute
    8. X marks the spot: Vector insertion is viral specific
    9. Despite darkness, nocturnal bees learn visual landmarks while foraging at night
    10. High Flux Isotope Reactor marks 400th cycle
    11. Study marks increased trends in infectious disease occurrences in our oceans

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:2/6/2019)... ... February 04, 2019 , ... uBiome, the leader microbial ... to help individuals understand how the gut microbes may increase the risk of ... eat foods that contain choline and L-carnitine, such as red meat and eggs, ...
    (Date:2/2/2019)... FRANCISCO (PRWEB) , ... January 31, 2019 , ... ... leader in microbial genomics, has awarded microbiome research support in study design, planning, ... Behr, PhD, HCLD, Professor of Obstetrics and Gynecology, and Dr. Sara Vaughn, MD, ...
    (Date:1/30/2019)... ... January 30, 2019 , ... ... supports high-growth, high-impact life science and biotechnology companies, announced today that it ... foundations and disease-focused venture funds to discuss their investment philosophies, explain their ...
    Breaking Biology News(10 mins):
    (Date:1/24/2019)... ... , ... Outsourcing trials to contract research organizations (CRO) can ... creation and management generally requires manual effort. Additionally, each vendor organizes tasks and ... can ultimately lead to study start delays and change orders because tasks were ...
    (Date:1/20/2019)... ... ... The American Society of Gene & Cell Therapy (ASGCT) is proud to announce ... 2019. Designed by ASGCT committee volunteers in coordination with patient advocacy groups, the new ... the status and promise of gene and cell therapies. , Gene Therapy 101 ...
    (Date:1/11/2019)... ... 2019 , ... Boekel Scientific launches its new Touch Screen ... This advanced and intuitive medical device was designed in conjunction with stationary and ... busiest donor stations with new-to-the industry features to improve efficiency and operational ease. ...
    (Date:1/8/2019)... ... January 07, 2019 , ... ... into Noninvasix. This represents the second investment AngelMD has made into Noninvasix in ... Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure brain ...
    Breaking Biology Technology:
    Cached News: